Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: bevacizumab + doxorubin hydrochloride liposme|DRUG: Bevacizumab
Sponsor: Swiss Group for Clinical Cancer Research